Kevin Brosseau is seeking to stem the flow of a deadly opioid not only to reverse U.S. tariffs but to end domestic drug deaths.
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...